Navigation Links
Volcano Presentation at Thomas Weisel Conference to Be Webcast
Date:8/28/2008

SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Thomas Weisel Partners 2008 Healthcare Conference on Thursday, September 4.

The presentation by Scott Huennekens, president and chief executive officer, will begin at 3:50 p.m., Eastern Daylight Time (12:50 p.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.veracast.com/webcasts/twp/healthcare08/54213429.cfm or via the company's website at http://www.volcanocorp.com.

Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) tissue characterization and ChromaFlo(R). Volca
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
2. Volcano Announces Acquisition of Novelis, Inc.
3. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
4. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
5. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
6. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
9. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
10. Volcano Announces Closing of CardioSpectra Acquisition
11. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Sergei Filippov (MIPT and Russian Quantum Center at ... Czech Republic, and the Institute of Physics in ... quantum entanglement of particles passing through an amplifier ... distances. Details are provided in an article published ... (see preprint). , Quantum entangled particles are considered ...
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Think Drinks are a neuroscience-backed drink ... term. They are the first functional focus beverage to ... an alternative to the temporary fix associated with energy ... July 29, 2014, with hopes to raise $50,000 over ... - http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks ...
(Date:7/23/2014)... Columbia, MD (PRWEB) July 23, 2014 ... Station, an LC/MS amino acid analysis system developed ... analysis, the UF-Amino Station can analyze 38 amino ... , The UF-Amino Station achieves high-speed analysis utilizing ... spectrometer. The LCMS-2020 provides accurate analytical results even ...
(Date:7/23/2014)... July 23, 2014  Having the right people at ... to accelerating business growth and achieving clinical and operational ... (AHA) Leadership Summit, July 20-22, 2014, in ... hospital executives and healthcare experts discussing how partnerships have ... , President & Chief Executive Officer of Cape Regional ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2
... Ten new validation studies,were published during 2007 ... the total number of studies published to 65., ... increase in interest from US and,European institutes" said ... highly respected academic medical institutions and teaching hospitals,have ...
... notes, and extended the maturity to 2011 on an additional $23.25 million ... ... Therapeutics, Inc.,("CTI" or the "Company") (Nasdaq and MTAX: CTIC) today announced that ... Notes") due 2011 and 5,459,574 shares of its common stock,no par value ...
... Board of Directors of Shire plc (LSE: SHP,NASDAQ: ... announces its Board succession plans. Dr James H ... Emmens (56) will succeed him,as Non-Executive Chairman. Angus ... Board changes will become effective at Shire,s AGM ...
Cached Biology Technology:2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators 2Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes 2Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes 3Shire plc: Board Changes 2Shire plc: Board Changes 3Shire plc: Board Changes 4
(Date:7/23/2014)... Mass. Honey bees, especially the young, are highly ... work together to maintain temperatures within a narrow range. ... biologist at Tufts University,s School of Arts and Sciences, ... excess heat within a hive in process similar to ... blood vessels and skin. , "This study shows ...
(Date:7/23/2014)... alongside decades of in-depth monitoring, has provided unique ... a population of top-predators. Published in Nature ... seals have significantly altered in accordance with changes ... conditions. Despite a shift in the population towards ... through generations, leaving the population in decline. ...
(Date:7/23/2014)... tissue samples cultured from cystic fibrosis patients, scientists at ... Lung Institute have shown that a new CF drug ... drug. , The finding, published today in the journal ... CFTR protein becomes unstable and loses its ability to ... drugs. The research offers several insights into how novel ...
Breaking Biology News(10 mins):How honey bees stay cool 2Genetic study shows major impact of climate change on Antarctic fur seals 2Genetic study shows major impact of climate change on Antarctic fur seals 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4
... In an international human genetic study, researchers at UT Southwestern ... disease lupus, and its location on the X chromosome might ... the disease than males. Identifying this gene, IRAK1, as ... Chandra Mohan, professor of internal medicine and senior author of ...
... nervous system or brain. So how do individual bacterial ... a biofilm "decide" between different physiological processes (such as ... In the prestigious 2009 Fleming lecture, given ... (Monday 30 March) Dr Nicola Stanley-Wall from the University ...
... coastal mudflats have an essential role to play in ... by Dr Efe Aganbi and colleagues from the University ... meeting at Harrogate today (Monday 30 April), reveals essential ... depending on whether or not oxygen is present. In ...
Cached Biology News:Gene linked to lupus might explain gender difference in disease risk 2Microbes in mud flats clean up oil spill chemicals 2
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
Parathyroid Hormone Receptor 2 [PTHR2]...
... Desalt Spin Columns contain a proprietary high-performance ... exceptional desalting and protein-recovery characteristics compared to ... low as 25 g/ml of protein can ... > 95% retention of salts and other ...
Biology Products: